Literature DB >> 20949298

Osteomalacia revisited : a report on 28 cases.

Laia Gifre1, Pilar Peris, Ana Monegal, Maria Jesús Martinez de Osaba, Luisa Alvarez, Núria Guañabens.   

Abstract

The aim of this study was to analyse the clinical manifestations and the most frequent causes of osteomalacia (OM) in a group of 28 patients diagnosed with this disorder during a 20-year period. OM was diagnosed by bone biopsy and/or by Bingham and Fitzpatrick criteria (two of the following: low calcium, low phosphate, elevated total alkaline phosphatase [total AP] or suggestive radiographs). Of these patients, 13 had vitamin D deficiency OM (VD-OM), 14 hypophosphatemic OM (HypoP-OM) and one had OM-associated hypophosphatasia. Deficient sun exposure and celiac disease were the most frequent etiologies of VD-OM, whereas most HypoP-OM were hereditary forms. The main clinical symptoms were polyarthralgias (89%), frequently associated with fractures (75%). Fifty seven percent had densitometric criteria of osteoporosis. Patients with VD-OM showed significantly higher total AP and PTH serum values, but lower vitamin D, serum calcium, calciuria and bone mass than patients with HypoP-OM. Conversely, HypoP-OM patients had significantly lower serum phosphate and higher phosphaturia than patients with VD-OM. Briefly, high total AP, low serum calcium and low serum phosphate were observed in 85%, 65% and 15%, respectively, of patients with VD-OM, being observed in 64%, 14% and 100%, respectively, of HypoP-OM patients. Nearly 50% of these latter showed increased FGF23 levels. In conclusion, in this study, the frequencies of HypoP-OM and VD-OM were similar. The most frequent laboratory abnormalities were increased total AP and decreased serum phosphate. A urinary calcium loss of less than 50 mg/dl was highly discriminatory for VD-OM and a serum phosphate less than 2.3 mg/dl was also high discriminatory for HypoP-OM. Low densitometric values and fractures were frequent among these patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20949298     DOI: 10.1007/s10067-010-1587-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  36 in total

Review 1.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

Review 2.  FGF23 is a hormone-regulating phosphate metabolism--unique biological characteristics of FGF23.

Authors:  Seiji Fukumoto; Takeyoshi Yamashita
Journal:  Bone       Date:  2007-01-04       Impact factor: 4.398

3.  Changes in bone mineral density following treatment of osteomalacia.

Authors:  Rajiv Bhambri; Vaishali Naik; Nidhi Malhotra; Shilpa Taneja; Saurabh Rastogi; Uma Ravishanker; Ambrish Mithal
Journal:  J Clin Densitom       Date:  2006-03-27       Impact factor: 2.617

4.  The enthesopathic changes of hypophosphatemic osteomalacia in adults: radiologic findings.

Authors:  M I Burnstein; J P Lawson; S R Kottamasu; B I Ellis; J Micho
Journal:  AJR Am J Roentgenol       Date:  1989-10       Impact factor: 3.959

5.  Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3.

Authors:  Bettina Lorenz-Depiereux; Anna Benet-Pages; Gertrud Eckstein; Yardena Tenenbaum-Rakover; Janine Wagenstaller; Dov Tiosano; Ruth Gershoni-Baruch; Norbert Albers; Peter Lichtner; Dirk Schnabel; Ze'ev Hochberg; Tim M Strom
Journal:  Am J Hum Genet       Date:  2005-12-09       Impact factor: 11.025

6.  High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors.

Authors:  M Z Erkal; J Wilde; Y Bilgin; A Akinci; E Demir; R H Bödeker; M Mann; R G Bretzel; H Stracke; M F Holick
Journal:  Osteoporos Int       Date:  2006-05-23       Impact factor: 4.507

7.  A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy.

Authors:  A J Black; J Topping; B Durham; R G Farquharson; W D Fraser
Journal:  J Bone Miner Res       Date:  2000-03       Impact factor: 6.741

8.  Noninvasive testing in the diagnosis of osteomalacia.

Authors:  C T Bingham; L A Fitzpatrick
Journal:  Am J Med       Date:  1993-11       Impact factor: 4.965

Review 9.  Musculoskeletal manifestations of osteomalacia and rickets.

Authors:  Antonio J Reginato; Juliet Arambulo Coquia
Journal:  Best Pract Res Clin Rheumatol       Date:  2003-12       Impact factor: 4.098

10.  Bone mineral density and bone scintigraphy in adult Saudi female patients with osteomalacia.

Authors:  Mahmoud I El-Desouki; Saleh M Othman; Mona A Fouda
Journal:  Saudi Med J       Date:  2004-03       Impact factor: 1.484

View more
  15 in total

1.  Osteomalacia mimicking spondyloarthropathy: a case report.

Authors:  Y Garip; M Dedeoglu; H Bodur
Journal:  Osteoporos Int       Date:  2014-04-24       Impact factor: 4.507

2.  Drug-induced osteoporosis/osteomalacia: analysis in the French and Spanish pharmacovigilance databases.

Authors:  Quentin Dardonville; Esther Salguiero; Vanessa Rousseau; Leila Chebane; Jean Luc Faillie; Sophie Gautier; Jean Louis Montastruc; Alfonso Carvajal; Haleh Bagheri
Journal:  Eur J Clin Pharmacol       Date:  2019-08-29       Impact factor: 2.953

Review 3.  Hypophosphatemic osteomalacia induced by low-dose adefovir therapy: focus on manifestations in the skeletal system and literature review.

Authors:  Du Hwan Kim; Duk Hyun Sung; Yong Ki Min
Journal:  J Bone Miner Metab       Date:  2012-09-14       Impact factor: 2.626

4.  Hypophosphatemia in the setting of metabolic bone disease: case reports and diagnostic algorithm.

Authors:  Alvin Lee Day; Sarah L Morgan; Kenneth G Saag
Journal:  Ther Adv Musculoskelet Dis       Date:  2018-06-15       Impact factor: 5.346

Review 5.  [Metabolic bone disease osteomalacia].

Authors:  M A Reuss-Borst
Journal:  Z Rheumatol       Date:  2014-05       Impact factor: 1.372

6.  Hypophosphatemic osteomalacia: a case simulating anklylosing spondylitis treated with anti-TNF therapy.

Authors:  F Sivas; F G Yurdakul; M Durak; G Hatipoğlu; E D Önal; H Bodur
Journal:  Osteoporos Int       Date:  2016-09-12       Impact factor: 4.507

7.  Vitamin D-deficient osteomalacia due to excessive self-restrictions for atopic dermatitis.

Authors:  Kiyoshi Shikino; Masatomi Ikusaka; Tomoko Yamashita
Journal:  BMJ Case Rep       Date:  2014-07-04

8.  Fanconi Syndrome Leading to Hypophosphatemic Osteomalacia Related to Tenofovir Use.

Authors:  Mana Rao; Liam Dadey; Thomas Glowa; Peter Veldkamp
Journal:  Infect Dis Rep       Date:  2021-05-24

9.  Vitamin D deficiency and biochemical variations among urban Saudi adolescent girls according to season.

Authors:  Riad A Sulimani; Ashry G Mohammed; Assim A Alfadda; Suliman N Alshehri; Abdulaziz M Al-Othman; Nasser M Al-Daghri; David A Hanley; Aliya A Khan
Journal:  Saudi Med J       Date:  2016-09       Impact factor: 1.484

10.  Adefovir dipivoxil induced hypophosphatemic osteomalacia in chronic hepatitis B: a comparative study of Chinese and foreign case series.

Authors:  Nan Chen; Jian-Bo Zhang; Qiujie Zhang; Yun-Peng Zhao; Li-Yan Li; Li-Wei Liu; Fei Yu; Xin Yu; Tao Peng; Kuan-Xiao Tang
Journal:  BMC Pharmacol Toxicol       Date:  2018-05-16       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.